Mohamed, A., Niedzwiecki, D., Baker, J. H., Vinesett, R., Martin, P. L., Driscoll, T. A., … Szabolcs, P. (2008). 208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT). In Biology of Blood and Marrow Transplantation (Vol. 14, pp. 77–77). Elsevier BV. https://doi.org/10.1016/j.bbmt.2007.12.217

Mohamed, A., D. Niedzwiecki, J. H. Baker, R. Vinesett, P. L. Martin, T. A. Driscoll, V. K. Prasad, S. Parikh, J. Kurtzberg, and P. Szabolcs. “208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT).” In Biology of Blood and Marrow Transplantation, 14:77–77. Elsevier BV, 2008. https://doi.org/10.1016/j.bbmt.2007.12.217.

Mohamed A, Niedzwiecki D, Baker JH, Vinesett R, Martin PL, Driscoll TA, et al. 208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT). In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2008. p. 77–77.

Mohamed, A., et al. “208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT).” Biology of Blood and Marrow Transplantation, vol. 14, no. 2, Elsevier BV, 2008, pp. 77–77. Crossref, doi:10.1016/j.bbmt.2007.12.217.

Mohamed A, Niedzwiecki D, Baker JH, Vinesett R, Martin PL, Driscoll TA, Prasad VK, Parikh S, Kurtzberg J, Szabolcs P. 208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT). Biology of Blood and Marrow Transplantation. Elsevier BV; 2008. p. 77–77.